E Fund Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.1K | Buy |
20,258
+1,093
| +6% | +$3.78K | ﹤0.01% | 384 |
|
|
2025
Q1 | $50.2K | Buy |
19,165
+1,511
| +9% | +$3.96K | ﹤0.01% | 393 |
|
|
2024
Q4 | $72.7K | Buy |
17,654
+6,104
| +53% | +$25.1K | ﹤0.01% | 386 |
|
|
2024
Q3 | $81.8K | Sell |
11,550
-228
| -2% | -$1.61K | ﹤0.01% | 345 |
|
|
2024
Q2 | $76.8K | Sell |
11,778
-10,152
| -46% | -$66.2K | ﹤0.01% | 310 |
|
|
2024
Q1 | $182K | Buy |
21,930
+4,444
| +25% | +$36.9K | 0.01% | 354 |
|
|
2023
Q4 | $193K | Sell |
17,486
-1,917
| -10% | -$21.1K | 0.01% | 288 |
|
|
2023
Q3 | $163K | Sell |
19,403
-14,305
| -42% | -$120K | 0.01% | 271 |
|
|
2023
Q2 | $423K | Buy |
33,708
+8,516
| +34% | +$107K | 0.03% | 154 |
|
|
2023
Q1 | $415K | Buy |
25,192
+512
| +2% | +$8.43K | 0.03% | 153 |
|
|
2022
Q4 | $369K | Buy |
24,680
+11,197
| +83% | +$167K | 0.03% | 195 |
|
|
2022
Q3 | $302K | Sell |
13,483
-6,992
| -34% | -$157K | 0.03% | 238 |
|
|
2022
Q2 | $343K | Buy |
20,475
+12,110
| +145% | +$203K | 0.03% | 211 |
|
|
2022
Q1 | $250K | Buy |
+8,365
| New | +$250K | 0.01% | 257 |
|